|
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor
An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that interferes with the action of carbonyl reductase (NADPH), EC 1.1.1.184.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
|
|
|
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
non-steroidal anti-inflammatory drug
An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
antirheumatic drug
A drug used to treat rheumatoid arthritis.
peripheral nervous system drug
A drug that acts principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system.
|
|
|
4-butyl-1,2-diphenylpyrazolidine-3,5-dione
|
|
3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine
|
ChemIDplus
|
|
4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE
|
PDBeChem
|
|
4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione
|
ChemIDplus
|
|
Phenbutazone
|
KEGG COMPOUND
|
Phenylbutazon
|
ChemIDplus
|
|
Phenylbutazone
|
KEGG COMPOUND
|
|
290080
|
Beilstein Registry Number
|
Beilstein
|
|
290080
|
Reaxys Registry Number
|
Reaxys
|
|
50-33-9
|
CAS Registry Number
|
KEGG COMPOUND
|
2-
